zidovudine has been researched along with Disease Exacerbation in 194 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 134 (69.07) | 18.2507 |
| 2000's | 44 (22.68) | 29.6817 |
| 2010's | 14 (7.22) | 24.3611 |
| 2020's | 2 (1.03) | 2.80 |
| Authors | Studies |
|---|---|
| Fortuin, R; Sitole, L; Tugizimana, F | 1 |
| Dong, Z; Wang, X; Yan, Q | 1 |
| Borok, M; Campbell, TB; Erlandson, KM; Fiorillo, S; Gudza, I; Gwanzura, L; Ndemera, B; Schooley, RT | 1 |
| Holla, P; Jameel, S; Munshi, SU; Panda, H; Rewari, BB | 1 |
| Farquhar, C; John-Stewart, GC; Otieno, PA; Richardson, BA; Unger, JA; Wamalwa, D | 1 |
| Bagratee, J; Grobler, A; Maharaj, NR; Moodley, D; Nandlal, V; Richardson, P | 1 |
| Imai, Y; Kawamoto, M; Kohara, N; Sekiya, H; Togo, M; Yoshimura, H | 1 |
| Berendes, S; Campbell, TB; Cardoso, SW; Christian, P; Gupta, A; Gupte, N; Kanyama, C; Lama, JR; Mwelase, N; Pillay, S; Riviere, C; Samaneka, W; Semba, RD; Shivakoti, R; Sugandhavesa, P; Tang, AM; Yang, WT | 1 |
| Bierman, W; Bravenboer, B; Gisolf, E; Groeneveld, P; Hoepelman, AI; Koopmans, PP; Langebeek, N; Legrand, JC; Mulder, PG; Richter, C; Sprenger, HG; Ten Kate, RW; Ten Napel, CH; van der Werf, Ts; Vriesendorp, R | 1 |
| Donnen, P; Koy, T; Malandala, GL; Mukumbi, H; Wilmet-Dramaix, M | 1 |
| Babiker, AG; Cotton, MF; Gibb, DM; Jean-Philippe, P; Madhi, SA; McIntyre, JA; Steyn, J; Violari, A | 1 |
| Grossman, ME; Husain, S; MacGregor-Cortelli, B; Marneros, AG; Neylon, E; Nuovo, GJ; O'Connor, OA; Patterson, M; Silvers, DN; Zain, JM | 1 |
| Black, V; Guidozzi, F | 1 |
| Diaz, C; Hanson, C; LaRussa, P; Lu, M; Mendez, H; Meyer, WA; Mofenson, LM; Rich, K; Thompson, B; Tuomala, RE; Watts, DH | 1 |
| Abaine, D; Aber, M; Ahimbisibwe, F; Akao, J; Akuma, S; Amuron, B; Amurwon, J; Angweng, E; Anywar, W; Atwiine, D; Atwiine, S; Awio, P; Babiker, A; Babiker, AG; Bafana, T; Bagaya, L; Bahendeka, S; Bakeinyaga, GT; Barungi, G; Bassett, M; Bohannon, J; Boocock, K; Borok, M; Bray, D; Breckenridge, A; Bulaya-Tembo, R; Buluma, E; Burke, A; Burke, C; Byakwaga, H; Byamukama, A; Byaruhanga, R; Chakonza, L; Chidziva, E; Chigwedere, E; Chimanzi, J; Chimbetete, C; Chirairo, H; Chirara, M; Chirema, O; Chitsungo, S; Chivhunga, T; Coutinho, A; Darbyshire, JH; Drasiku, A; Dunn, D; Enzama, R; Etukoit, B; Fadhiru, K; Ferrier, A; Florence, A; Foster, S; Gazzard, B; Generous, L; Gibb, DM; Gilks, C; Gilks, CF; Goodall, R; Grosskurth, H; Grundy, C; Haguma, W; Hakim, J; Hill, C; Hughes, P; Jamu, A; Jangano, M; Jones, S; Kabanda, J; Kabuye, G; Kagina, G; Kajungu, D; Kaleebu, P; Kambungu, A; Kankunda, R; Karungi, J; Kasirye, R; Katabira, E; Katabira, H; Katundu, P; Khauka, P; Kigozi, J; Kikaire, B; Kityo, C; Komugyena, J; Kulume, R; Kusiima, A; Kyomugisha, H; Labeja, O; Lara, AM; Latif, A; Levin, J; Lubwama, E; Lutwama, F; Lyagoba, F; Machingura, I; Machingura, J; Makota, S; Mambule, I; Mapinge, F; Mapuchere, C; Massa, R; Matenga, J; Matongo, M; Maweni, C; Mawora, A; McCormick, A; McLaren, A; Mdege, N; Moyo, K; Muchabaiwa, L; Mudzingwa, S; Mufuka-Kapuya, C; Muganzi, A; Mugisha, A; Mugurungi, O; Mugyenyi, P; Muhweezi, D; Muhwezi, A; Mukiibi, S; Mukose, A; Mulindwa, G; Mulindwa, M; Munderi, P; Murungi, S; Musana, H; Musoro, G; Mutowo, J; Mutsai, S; Muvirimi, C; Muyingo, S; Muzambi, M; Mwebesa, D; Mwesigwa, P; Nabankema, E; Nabongo, P; Naidoo, B; Nairuba, R; Nakahima, W; Nakazibwe, M; Nakiyingi, J; Nalumenya, R; Namale, L; Namara, W; Namata, I; Namazzi, A; Namuli, T; Namyalo, M; Nanfuka, A; Nanfuka, R; Nassuna, G; Ndembi, N; Newland, C; Ngorima, N; Nimwesiga, E; Nsibambi, D; Nyachwo, L; Nyiraguhirwa, D; Ochai, R; Ojiambo, H; Ojiambo, W; Oketta, F; Omony, W; Otim, T; Oyugi, J; Palfreeman, A; Pascoe, M; Pearce, G; Peto, L; Peto, T; Phiri, M; Pillay, D; Pozniak, A; Puddephatt, C; Rahim, S; Rauchenberger, M; Reid, A; Robertson, V; Ronald, A; Rooney, J; Ruberantwari, A; Rutikarayo, N; Sabiiti, J; Sadik, F; Sematala, F; Serwadda, D; Sheehan, S; Simango, M; Smith, M; Snowden, W; Spencer-Drake, C; Spyer, M; Ssali, F; Steens, JM; Svovanapasis, P; Takubwa, J; Taylor, K; Taziwa, F; Tinago, G; Todd, J; Tugume, S; Tukamushaba, J; Tumukunde, D; Tumusiime, C; Twijukye, C; Vere, L; Waita, R; Wakholi, BN; Walker, AS; Walusimbi, J; Wangati, K; Wanyama, J; Wapakhabulo, AC; Warambwa, C; Warara, R; Wavamunno, P; Weller, I; Whitworth, J; Wilkes, H; Winogron, D; Yirrell, D; Zalwango, A; Zalwango, E; Zawedde, C; Zengeza, E | 1 |
| Babiker, AG; Darbyshire, JH; Gibb, DM; Gilks, CF; Grosskurth, H; Kityo, C; Mugyenyi, P; Munderi, P; Reid, A; Ssali, F; Walker, AS | 1 |
| Tolle, MA | 1 |
| Davey, RT; Dewar, R; Follmann, DA; Herpin, B; Huang, CY; Kovacs, J; Lane, HC; Masur, H; Metcalf, JA; Polis, MA; Shah, A; Shen, J; Tavel, JA; Vasudevachari, MB | 1 |
| Bosire, R; Brown, ER; Choi, RY; Farquhar, C; Fowke, KR; John-Stewart, G; Juno, J; Lohman-Payne, B; Oyugi, JO | 1 |
| Drake, AL; Emery, S; Farquhar, C; John-Stewart, GC; Kiarie, JN; Matemo, DN; Ongecha-Owuor, F; Overbaugh, J; Richardson, B; Roxby, AC; Wald, A | 1 |
| Arnulf, B; Bazarbachi, A; Besson, C; Gonin, C; Hermine, O; Panelatti, G; Plumelle, Y | 1 |
| Bettendorf, DM; Christopherson, C; D'Aquila, RT; Hammer, SM; Katzenstein, DA; Lathey, JL; Tierney, C | 1 |
| Bardeguez, AD; Coombs, R; Cunningham, B; Fowler, MG; Frenkel, LM; Gandia, J; Huang, S; Jones, T; Maupin, R; Mofenson, LM; O'Sullivan, MJ; Shapiro, DE; Sperling, RS; Zorrilla, CD | 1 |
| Bethel, J; Fowler, MG; Harris, DR; Lambert, J; Mathieson, B; Meyer, WA; Mofenson, L; Nemo, G; Stiehm, ER; Watts, DH | 1 |
| Albert, J; Antonsson, L; Fenyö, EM; Karlsson, A; Karlsson, I; Leitner, T; Olde, B; Owman, C; Shi, Y | 1 |
| Babiker, AG; Walker, AS; White, IR | 1 |
| Becker, SL; Danehower, SC; Fusco, GP; Fusco, JS; Graham, NM; Hansen, NI; Justice, AC; Sherrill, BH; Stein, DS | 1 |
| Pezzotti, P; Phillips, A | 1 |
| Castillo, SA; DeJesus, E; Farthing, CF; Gough, K; Grinsztejn, B; Madison, SJ; McCarty, D; Schrader, SR; Sension, MG; Shortino, DD; Thomas, DA | 1 |
| Fahey, JL; Grossberg, SE; Johnston, DM; Kagan, J; Mildvan, D; Schock, BR; Spritzler, J | 1 |
| Chuang, LF; Chuang, RY; Chuang, TK; Doi, RH; Miyagi, T; Suzuki, S | 1 |
| Chang, FM; Lin, HC; Liu, CC; Wang, SM; Wu, CS | 1 |
| Gonzalez, RG; Hedreen, JC; Lipton, SA; Monti, L; Navia, BA; Rostasy, K | 1 |
| Bernard, M; Bouhour, D; Boulliat, J; Fleury, J; Laurent-Coriat, C; Tilikete, C; Vighetto, A | 1 |
| Barberá Farré, JR; Beato Pérez, JL; Cuadra García-Tenorio, F; Geijo Martínez, MP; Maciá Martínez, MA; Marcos Sánchez, F; Martínez Alfaro, E; Moreno Mendaña, JM; Rodríguez Zapata, M; Sanz Moreno, J; Sanz Sanz, J; Solera Santos, J | 1 |
| Bowornkitikajorn, P; Chearskul, S; Chokephaibulkit, K; Chotpitayasunondh, T; Phongsamart, W; Samkoset, R; Sutthent, R; Tarunothai, U; Vanprapar, N | 1 |
| Berk, DR; Falkovitz-Halpern, MS; Maldonado, YA; Ruiz, J; Sullivan, B | 1 |
| Desai, VG; Fuscoe, JC | 1 |
| Battegay, M; Huttner, AC; Kaufmann, GR; Opravil, M; Weber, R | 1 |
| Benmebarek, Y; Blanche, S; Dollfus, C; Douard, D; Faye, A; Firtion, G; Lechenadec, J; Meyer, L; Monpoux, F; Rouzioux, C; Tricoire, J; Warszawski, J | 1 |
| Berger, D; Elezović, I; Gotić, M; Marisavljević, D; Rolović, Z | 1 |
| Bakhtiari, M; Bell, S; Kuritzkes, DR | 1 |
| Coombs, RW; Crumpacker, CS; D'Aquila, RT; Japour, AJ; Johnson, VA; Kahn, JO; Kuritzkes, DR; Reichelderfer, PS; Richman, DD; Welles, S | 1 |
| Koot, M; Miedema, F; Roos, MT; Schellekens, PT; Tersmette, M | 2 |
| Calderón, EJ; Larder, B; Leal, M; Lissen, E; Luque, F; Medrano, FJ; Rey, C; Sánchez-Quijano, A; Torres, Y | 1 |
| Frank, JW; Leblanc, M; Major, C; McLaughlin, J; O'Shaughnessy, MV; Read, SE; Strathdee, SA | 1 |
| Collier, AC; Fischl, MA; Grimes, JM; Hirsch, MS; Lagakos, SW; Meng, TC; Phair, JP; Rooney, J; Stein, DS; Volberding, PA | 1 |
| Carr, A; Clumeck, N; Cooper, DA; Hirschel, BJ; Hoen, B; Kinloch-De Loës, S; Lazzarin, A; Mathiesen, L; Saurat, JH; Tindall, B | 1 |
| Chirgwin, K; Fleischman, H; Friedman, EA; Ifudu, O; Rao, TK; Tan, CC | 1 |
| Bryson, YJ; Deveikis, A; Frenkel, LM; Keller, M; Nielsen, K; Sim, MS; Stiehm, ER; Wei, LS | 1 |
| Church, JA; Dunkle, LM; Federici, ME; Goldsmith, JC; Harris, AT; Kaul, S; Kline, MW; Loewen, DF; Schultze, ME; Woods, L | 1 |
| Arasteh, K; Haase, W; Jablonowski, H; Ruf, B; Schomaker, U; Schrappe, M; Staszewski, S; Stellbrink, HJ; Stoehr, A; von Eisenhart Rothe, B | 1 |
| Beaulieu, R; Cameron, B; Dunkle, L; Gill, J; Montaner, JS; Raboud, J; Rachlis, A; Salomon, H; Schechter, MT; Smaldone, L; Tsoukas, C; Wainberg, MA | 1 |
| Besemer, D; Fong, SJ; Hoo, B; Irvine, B; Kern, DG; Pachl, C; Sheridan, PJ; Stempien, M; Todd, JA; Yeghiazarian, T | 1 |
| Cappelleri, JC; Chalmers, TC; Ioannidis, JP; Lau, J; Melville, B; Sacks, HS; Skolnik, PR | 1 |
| Broder, S; Mitsuya, H; Nguyen, BY; Pluda, JM; Venzon, DJ; Wyvill, KM; Yarchoan, R | 1 |
| Blattner, WA; Carrington, MN; Goedert, JJ; Kroner, BL; Mann, DL; Wilson, SE | 1 |
| De Gruttola, V; Tu, XM | 1 |
| Collier, AC | 1 |
| Richman, DD | 1 |
| Fouchier, RA; Groenink, M; Klein, MR; Koot, M; Meyaard, L; Miedema, F; Roos, MT; Schellekens, PT; Tersmette, M; Van't Wout, AB | 1 |
| Elford, J; Janossy, G; Lee, C; Pasi, J; Phillips, A; Sabin, C | 1 |
| Beall, G; Blick, G; Calabrese, LH; Conant, MA; Fisher, A; Galpin, JE; Goldstein, G; Grossman, HA; Hirsch, RL; Stampone, P | 1 |
| Barcherini, S; Bucciardini, R; Chiesi, A; Floridia, M; Giuliano, M; Mariotti, S; Seeber, A; Tomino, C; Vella, S | 1 |
| Flepp, M | 1 |
| Berglund, O; Elvin, K; Lidman, C; Lindbäck, S; Tynell, E | 1 |
| Girolami, A; Mares, M; Sartori, MT; Stocco, D; Zerbinati, P | 1 |
| Koot, M; Miedema, F; Schuitemaker, H | 1 |
| Allan, JD; Arduino, JM; Collier, AC; Feinberg, JE; Fischl, MA; Goldsmith, JC; Powderly, WG; Stanley, K; Stein, DS | 1 |
| Albert, J; Aperia, K; Fenyö, EM; Karlsson, A; Parsmyr, K; Sandström, E | 1 |
| Atoui, N; Bonardet, A; Conge, AM; Ducos, J; Huguet, MF; Reynes, J; Serre, A; Vendrell, JP | 1 |
| Dunn, D; Newell, ML; Peckham, C; Thorne, C | 1 |
| Endert, E; Godfried, MH; Lange, JM; Mulder, JW; Sauerwein, HP; van der Poll, T; Weverling, GJ | 1 |
| Benoit, S; Esinhart, J; Hamilton, JD; Hartigan, PM; Hill, A; Martin, D; O'Brien, WA; Rubin, M; Simberkoff, MS | 1 |
| Bucher, HC; Griffith, L | 1 |
| Costagliola, D; Mary-Krause, M | 1 |
| Day, PL; Diamond, GR; Dickinson, GM; Drusano, GL; Egorin, MJ; George, WL; Gordin, FM; Hamilton, JD; Hartigan, PM; Hawkes, CA; Jensen, PC; Kilmas, NG; Labriola, AM; O'Brien, WA; Oster, CN; Pazner, SB; Simberkoff, MS; Weinhold, KJ; Wray, NP | 1 |
| Jablonowski, H | 1 |
| Finkelstein, DM; Fischl, MA; He, W; Powderly, WG; Steigbigel, RT; Triozzi, PL | 1 |
| Adams, O; Jablonowski, H; Mauss, S; Willers, R | 1 |
| Borkowsky, W; Brady, MT; Brouwers, P; Bryson, YJ; Elkins, MM; Fikrig, S; Fowler, MG; Gelber, R; Hutton, N; Jimenez, E; McGrath, N; McIntosh, K; McSherry, G; Mitchell, CD; Rubinstein, A; Weintrub, PS; Wilfert, CM; Yogev, R | 1 |
| Basgoz, N; D'Aquila, RT; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Liou, SH; Myers, M; Niu, M; Sommadossi, JP; Timpone, J | 1 |
| Detels, R; Graham, NM; Hoover, DR; Mellors, JW; Park, LP; Phair, JP; Saah, AJ; Stein, DS | 1 |
| Cooper, DA; Harrigan, PR; Kinghorn, I; Lange, JM; Larder, BA; Lavelle, J; Lefkowitz, L; McKinnis, R; Moore, M; Mulder, JW; Pennington, KN; Ramirez-Ronda, C; Rooney, JF; Schooley, RT; St Clair, M; Steel, H | 1 |
| Antunes, F; Clotet, B; Doroana, M; Gatell, JM; Gil-Aguado, A; González-Lahoz, J; Jou, A; Kasparova, L; Miro, JM; Podzamczer, D; Saballs, P; Santamaria, JM; Thomis, J; Verdejo, J | 1 |
| Galli, M; Gervasoni, C; Lovicu, GF; Lupo, A; Moroni, M; Musicco, M; Niero, F; Radice, D; Ridolfo, AL; Riva, A; Rusconi, S; Voltolin, L | 1 |
| Cleator, GM; Lucas, GS; Mani, GS; Stoddart, RW; Vallely, PJ | 1 |
| Goldschmidt, RH; Moy, A | 1 |
| Bird, AG; Brettle, RP; Burns, S; Gore, SM; Leen, CS; MacCallum, L; McNeil, AJ; Richardson, AM; Yap, PL | 1 |
| Brettle, RP; Chiswick, A; Egan, V; Goodwin, GM; Pretsell, DO | 1 |
| Dally, LG; De Rienzo, B; Dianzani, F; Floridia, M; Fragola, V; Mazzotta, F; Milazzo, F; Moroni, M; Ortona, L; Pastore, G; Scalise, G; Sinicco, A; Tomino, C; Vella, S; Weimer, LE | 1 |
| Abe, S; Fujishima, T; Koba, H; Morita, S; Nakata, H; Shigehara, K; Shijubo, N | 1 |
| Gundacker, H; Hammer, SM; Haubrich, RH; Henry, WK; Hirsch, MS; Hughes, MD; Katzenstein, DA; Lederman, MM; Merigan, TC; Niu, M; Phair, JP; Schooley, RT | 1 |
| Elbeik, T; Fiscus, S; Gundacker, H; Hammer, SM; Hirsch, MS; Hughes, MD; Jackson, JB; Japour, A; Katzenstein, DA; Merigan, TC; Rasheed, S; Reichman, R | 1 |
| Abrams, D; Collins, G; Crane, L; Hodges, JS; Loveless, MO; Markowitz, N; Pettinelli, C; Reves, R; Saravolatz, LD; Stein, DS; Thompson, M; Winslow, DL | 1 |
| Bartlett, JA; Eron, JJ; Hill, AM; Johnson, J; Phillips, AN; Price, S; Rubin, M; Self, P | 1 |
| Esquivel-Pedraza, L; Ponce de León, S; Ramírez-Amador, VA | 1 |
| Fisher, AC; Goldstein, G; Hirsch, RL; Merigan, TC; Meyerson, LA; Winters, MA | 1 |
| Carter, WA; Hamill, AK; Klimas, N; Molavi, A; Salvato, PD; Strayer, DR; Thompson, CE; Thompson, KA; Ventura, D; Zheng, Z | 1 |
| Bravo, R; del Romero, J; García-Lerma, G; Gómez-Cano, M; González-Lahoz, J; Martín, R; Mas, A; Soriano, V | 1 |
| Brouwers, P; Farley, M; Lane, JR; Mueller, BU; Pizzo, PA; Robb, ML; Sei, S; Stewart, SK | 1 |
| Brichacek, B; Janoff, EN; Pirruccello, S; Stevenson, M; Swindells, S | 1 |
| Millard, PS | 1 |
| Baraia, J; Díez, F; Iribarren, JA; Miralles, P | 1 |
| Cross, A; Dellamonica, P; Dunkle, L; Gathe, J; Jemsek, JG; Mellors, JW; Murphy, R; Pavia, AT; Spruance, SL; Stool, E | 1 |
| Alliegro, MB; Dorrucci, M; Pezzotti, P; Phillips, AN; Rezza, G | 1 |
| Bartlett, J; Eron, JJ; Hill, AM; Johnson, J; Katlama, C; McDade, H; Sawyer, W; Staszewski, S | 1 |
| Aiuti, F; Angarano, G; Arlotti, M; d'Arminio Monforte, A; Galli, M; Gritti, F; La Regina, A; Lazzarin, A; Mazzotta, F; Milazzo, F; Moroni, M; Musicco, M; Paga, C; Visco, G | 1 |
| Almi, P; Catucci, M; De Milito, A; Gonnelli, A; Occhini, U; Romano, L; Rubino, M; Valensin, PE; Venturi, G; Zazzi, M | 1 |
| Brizzi, M; Ceccherini-Nelli, L; Forastieri, G; Iuliano, R; Mazzotta, F; Mecocci, L | 1 |
| Abrams, EJ; Baker, CJ; Englund, JA; Fowler, MG; Gershon, A; McKinney, RE; McSherry, GD; Pearson, D; Petrie, B; Raskino, C; Schliozberg, J; Sullivan, JL | 1 |
| Basgoz, N; Bremer, JW; D'Aquila, RT; Elbeik, T; Erice, A; Fischl, MA; Hirsch, MS; Hughes, MD; Johnson, VA; Kuritzkes, DR; Scott, WA; Spector, SA | 1 |
| Daar, ES; Hamilton, JD; Hartigan, PM; O'Brien, WA; Simberkoff, MS | 1 |
| Alberici, F; Bassetti, D; Cargnel, A; Carosi, G; Chiodo, F; Concia, E; Cremoni, L; Dianzani, F; Floridia, M; Fragola, V; Giannini, V; Gritti, FM; Mazzotta, F; Milazzo, F; Moroni, M; Ranieri, S; Ricciardulli, D; Seeber, AC; Sinicco, A; Tomino, C; Vella, S; Weimer, LE | 1 |
| Babiker, AG; Darbyshire, JH; Walker, S; White, IR | 2 |
| Andreoni, M; Ercoli, L; Galluzzo, C; Giannini, G; Nicastri, E; Sarmati, L; Vella, S | 1 |
| Casabianca, A; Chiarantini, L; Ciriolo, MR; Fraternale, A; Garaci, E; Magnani, M; Palamara, AT; Rotilio, G; Schiavano, GF | 1 |
| Balfour, HH; Chodakewitz, JA; Currier, JS; Demeter, LM; Deyton, LR; Eron, JJ; Feinberg, JE; Fischl, MA; Grimes, JM; Hammer, SM; Hughes, MD; Squires, KE | 1 |
| Bissuel, F; Cotte, L; Deruelle, E; Leriche-Guérin, K; Rougier, P; Trabaud, MA; Trépo, C | 1 |
| Bassett, R; Hughes, MD; Ioannidis, JP; Lau, J; Sacks, HS; Volberding, PA | 1 |
| Battegay, M; Egger, M; Flepp, M; Francioli, P; Hirschel, B; Malinverni, R; Rickenbach, M; Sudre, P; Vernazza, P; Wirz, M | 1 |
| Hartigan, PM; Huang, IW; Rabeneck, L; Souchek, J; Wray, NP | 1 |
| Bravo, R; Garćia-Lerma, G; Gómez-Cano, M; González-Lahoz, J; Heredia, A; Laguna, F; Martínez, P; Mas, A; Moreno, V; Soriano, V; Valencia, E; Vallejo, A; Villalba, N | 1 |
| Cisterna, R; Muñoz, J; Santamaría, JM; Teira, R; Virosta, M; Zubero, Z | 1 |
| Culnane, M; Gwynne, M; Hutcheon, N; Kline, MW; Lindsey, JC; McKinney, RE; Mitchell, WG; Nichols, S; Van Dyke, RB; Yogev, R | 1 |
| Bratt, G; Cochaux, P; Gilljam, G; Hinkula, J; Leandersson, AC; Samson, M; Sandström, E; Wahren, B | 1 |
| Cooper, DA; Gow, I; Harris, J; Jaramillo, AB; Kelleher, AD; McMurchie, M; Patou, G; Roggensack, M; Smith, DE; Walker, A | 1 |
| Barton, S; Blaxhult, A; Clotet, B; Goebel, FD; Hirschel, B; Katlama, C; Lundgren, JD; Pedersen, C; Phillips, AN; Vella, S | 1 |
| Byington, R; Elbeik, T; Fiscus, SA; Griffith, BP; Hammer, SM; Hughes, MD; Jackson, B; Japour, A; Katzenstein, DA; Lathey, JL; Pi, T; Rasheed, S; Reichman, R; Scott, W | 1 |
| Collier, AC; Coombs, RW; Corey, L; Panther, LA; Zeh, JE | 1 |
| Blatt, SP; Burke, DS; Chung, RC; Cohn, DL; Gardner, LI; Harris, RW; Harrison, SH; Hendrix, CW; Mayers, DL; Wagner, KF | 1 |
| DeMasi, R; Hill, AM; Montaner, JS | 1 |
| Conway, B; Cooper, D; Hall, D; Harris, M; Lange, JM; Montaner, JS; Myers, M; Reiss, P; Robinson, P; Smith, D; Vella, S; Wainberg, MA | 1 |
| Graham, NM | 1 |
| Rezza, G | 1 |
| Beaulieu, R; Gelmon, K; Read, S; Sawka, C; Shepherd, FA; Singer, J; Thuot, CA | 1 |
| Kavlick, MF; Mitsuya, H; Wyvill, K; Yarchoan, R | 1 |
| Araneta, RG; Hersh, AL; Maldonado, YA | 1 |
| Belohradsky, BH; Eberle, J; Gürtler, L; Hoffmann, F; Notheis, G; Petropoulou, T; Sölder, B; Wintergerst, U | 1 |
| Arienti, D; Clerici, M; Leal, M; Lissen, E; Medrano, FJ; Rey, C; Sanchez-Quijano, A; Torres, Y; Zagliani, A | 1 |
| Babiker, AG; Darbyshire, JH; Peto, TE; Walker, AS | 1 |
| Brouwers, P; Johnson, GM; Keller, A; McKinney, RE; McNamara, J; Mitchell, WG; Mofenson, L; O'Donnell, KJ; Spector, SA; Stanley, K; Wara, DW; Wiznia, A; Yogev, R; Yong, FH | 1 |
| Britto, P; Coombs, RW; Culnane, M; Cunningham, BE; Delfraissy, JF; Diaz, C; Harrison, DD; Jimenez, E; McSherry, GD; Scott, G; Shapiro, DE; Shearer, WT; Sperling, RS; Van Dyke, RB | 1 |
| Angelini, F; Cancrini, C; Cox, S; Gattinara, GC; Livadiotti, S; Orlandi, P; Romiti, ML; Rossi, P; Scaccia, S | 1 |
| Cooper, DA; Kaufmann, G; Kelleher, AD; Murray, JM | 1 |
| Makadon, HJ | 1 |
| Naper, J | 1 |
| Benatti, U; Casabianca, A; Chiarantini, L; De Flora, A; Fraternale, A; Magnani, M; Schiavano, GF; Tonelli, A; Vallanti, G | 1 |
| De Gruttola, V; Kim, S | 1 |
| Belfrage, E; Bohlin, AB; Christensson, B; Ehrnst, A; Lidin-Janson, G; Ljung, R; Navér, L; Sönnerborg, A | 1 |
| Flepp, M; Jost, J; Ledergerber, B; Opravil, M; Paris, D; Ruef, C; Weber, R; Zimmerli, S | 1 |
| Brigido, LF; Casseb, JR; Duarte, AJ; Fonseca, LA; Reingold, AL | 1 |
| Cornelisse, PG; Craib, KJ; Hogg, RS; Montaner, JS; Montessori, V; O'Shaughnessy, MV; Yip, B | 1 |
| Clewley, G; Devereux, HL; Emery, VC; Griffiths, PD; Lee, CA; Loveday, C; Phillips, AN; Sabin, CA | 1 |
| Abrams, EJ; Bulterys, M; Kuhn, L; Lambert, G; Nesheim, SR; Palumbo, P; Schoenbaum, EE; Vink, PE; Weedon, J | 1 |
| Baker, CJ; Barroga, CF; Englund, JA; Fangon, MC; Palumbo, PE; Raskino, C; Spector, SA | 1 |
| de Souza, RS; Gómez-Marín, O; Guasti, S; Mitchell, CD; O'Sullivan, MJ; Oliveira, RH; Scott, GB | 1 |
| Bucy, RP; Gnann, JW; Goepfert, PA; Kilby, JM; Miller, AP; Saag, MS; Sillers, M | 1 |
| Baker, CJ; Brouwers, P; Englund, JA; Lifschitz, MC; McGrath, NM; Nichols, SL; Nozyce, M; Pearson, DA; Raskino, C | 1 |
| Church, JA; Cutrell, A; Emmanuel, P; Hetherington, S; Mitchell, C; Nelson, RP; Richardson, CG; Sáez-Llorens, X; Sleasman, J; Spreen, W; Van Dyke, R; Wiznia, A | 1 |
| Anastos, K; Augenbraun, M; Berhane, K; Cohen, M; Gange, SJ; Levine, AM; Masri-Lavine, L; Newman, M; Sanchez, M; Watts, H; Young, M | 1 |
| Loveday, C | 1 |
| James, JS | 1 |
| Mascolini, M | 1 |
| Randall, P | 1 |
| Doepel, L; Folkers, G | 1 |
| Gilden, D | 1 |
| Asjö, B; Berg, OG; Dyrhol-Riise, AM; Kleivbo, S; Olofsson, J; Voltersvik, P | 1 |
| Gray, L; Levy, J; Newell, ML; Peckham, C; Thorne, C | 1 |
| Aramideh, M; Koelman, JH; Koopmans, RP; Stam, J | 1 |
| Arduino, JM; Collier, AC; Fischl, MA; Spiegelman, D; Stanley, K | 1 |
| Antinori, A; Bruno, R; Bugarini, R; Chigiotti, S; Chirianni, A; De Luca, A; De Stefano, C; Gritti, F; Monforte, Ade A; Moroni, M; Mussini, C; Perrella, O; Pezzotti, P; Piazza, M; Pizzigallo, E; Tirelli, U; Vigevani, GM | 1 |
| Chadapaud, S; Halfon, P; Hittinger, G; Khiri, H; Lafeuillade, A; Poggi, C | 1 |
| Bosch, RJ; Coombs, RW; Demeter, LM; Fischl, MA; Fiscus, SA; Grimes, JM; Hammer, SM; Hughes, MD; Jackson, JB; Spector, SA; Squires, KE | 1 |
14 review(s) available for zidovudine and Disease Exacerbation
| Article | Year |
|---|---|
Opioids and the progression of simian AIDS.
Topics: Animals; Disease Progression; Humans; Immune System; Macaca mulatta; Morphine; Mutation; Narcotics; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Virus Replication; Zidovudine | 2005 |
Immunologic and virologic markers determining progression to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Biomarkers; CD4 Lymphocyte Count; Disease Progression; HIV-1; Humans; Prognosis; T-Lymphocytes; Zidovudine | 1995 |
Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness.
Topics: Acquired Immunodeficiency Syndrome; Disease Progression; HIV Infections; Humans; Odds Ratio; Randomized Controlled Trials as Topic; Regression Analysis; Time Factors; Zidovudine | 1995 |
Early intervention in HIV infection: where are we?
Topics: CD4 Lymphocyte Count; Controlled Clinical Trials as Topic; Disease Progression; Follow-Up Studies; HIV Infections; Humans; Multicenter Studies as Topic; Quality of Life; Randomized Controlled Trials as Topic; Survival Rate; Zidovudine | 1994 |
Resistance, drug failure, and disease progression.
Topics: Antiviral Agents; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1994 |
Changing virus-host interactions in the course of HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; CD4-Positive T-Lymphocytes; Disease Progression; HIV Infections; HIV-1; Humans; Immunity, Cellular; Lymphocyte Depletion; Zidovudine | 1994 |
Immunological and virological markers determining progression to AIDS.
Topics: Biomarkers; CD4 Lymphocyte Count; Disease Progression; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Phenotype; Predictive Value of Tests; Prognosis; Zidovudine | 1994 |
Recent development on research in AIDS pathogenesis.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Cytopathogenic Effect, Viral; Disease Progression; HIV Infections; HIV-1; Humans; Macrophages; Phenotype; Prognosis; Virulence; Zidovudine | 1994 |
Studies of zidovudine in combination with didanosine and zalcitabine.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Safety; Zalcitabine; Zidovudine | 1995 |
[Anti-retroviral treatment. Treatment in special situations: acute infection, pregnancy, central nervous system involvement, thrombocytopenia, accidental exposure].
Topics: Accidents, Occupational; Acute Disease; AIDS Dementia Complex; Animals; Anti-HIV Agents; Clinical Trials as Topic; Combined Modality Therapy; Disease Progression; Female; HIV Infections; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Rats; Splenectomy; Thrombocytopenia; Zidovudine | 1996 |
Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials.
Topics: Adolescent; Adult; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Disease Progression; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; United States; Zidovudine | 1997 |
Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Randomized Controlled Trials as Topic; Survival Rate; Time Factors; Zalcitabine; Zidovudine | 1999 |
Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.
Topics: Acute Disease; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chronic Disease; Disease Progression; Drug Therapy, Combination; Fever; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Syndrome; Viral Load; Zidovudine | 2000 |
International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance.
Topics: Dideoxynucleosides; Disease Progression; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; HIV Infections; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 2001 |
78 trial(s) available for zidovudine and Disease Exacerbation
| Article | Year |
|---|---|
Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Dideoxynucleosides; Disease Progression; Female; Herpesvirus 8, Human; HIV-1; Humans; Lamivudine; Male; Middle Aged; Odds Ratio; Pilot Projects; Prospective Studies; RNA, Viral; Sarcoma, Kaposi; Survival Analysis; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Zidovudine; Zimbabwe | 2014 |
Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Body Mass Index; C-Reactive Protein; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Didanosine; Disease Progression; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Multivariate Analysis; Oligopeptides; Prospective Studies; Pyridines; Risk Factors; Selenium; World Health Organization; Zidovudine | 2014 |
A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study.
Topics: Adult; Aged; Anti-HIV Agents; Belgium; CD4 Lymphocyte Count; Clinical Protocols; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Lipids; Male; Middle Aged; Netherlands; Prospective Studies; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2015 |
Early antiretroviral therapy and mortality among HIV-infected infants.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; Treatment Failure; Zidovudine | 2008 |
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
Topics: Adenine; Adolescent; Adult; Africa; Aged; Anemia; Anti-Retroviral Agents; CD4 Lymphocyte Count; Creatinine; Dideoxynucleosides; Disease Progression; Drug Monitoring; Female; Glomerular Filtration Rate; Hemoglobins; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Neutropenia; Neutrophils; Nevirapine; Organophosphonates; RNA, Viral; Tenofovir; Urea; Viral Load; Zidovudine | 2010 |
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Topics: Adult; Body Weight; CD4 Lymphocyte Count; Dideoxynucleosides; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Uganda; Viral Load; Zidovudine | 2010 |
Interferon-alpha produces significant decreases in HIV load.
Topics: Adult; CD4-Positive T-Lymphocytes; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; HIV Infections; Humans; Immunophenotyping; Interferon-alpha; Male; Survival Analysis; Viral Load; Zidovudine | 2010 |
Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
Topics: Acyclovir; Antiviral Agents; Biomarkers; CD4 Antigens; Disease Progression; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Kenya; Linear Models; Nevirapine; Postpartum Period; Pregnancy; RNA, Viral; Valacyclovir; Valine; Zidovudine | 2012 |
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; DNA, Viral; HIV-1; Humans; Multivariate Analysis; Prognosis; RNA, Viral; Zalcitabine; Zidovudine | 2003 |
Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Drug Resistance, Viral; Female; Follow-Up Studies; Genotype; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; RNA, Viral; Survival Analysis; Viral Load; Zidovudine | 2003 |
Progression of HIV disease among women following delivery.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Combined Modality Therapy; Disease Progression; Female; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunoglobulins, Intravenous; Longitudinal Studies; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; RNA, Viral; Treatment Outcome; Zidovudine | 2003 |
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2004 |
[Clinical trial comparing efficacy and safety of four highly active antiretroviral therapy (HAART) in antiretroviral-naive treatment with advanced HIV infection].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Didanosine; Disease Progression; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Ritonavir; Stavudine; Zidovudine | 2006 |
Initiation of antiretroviral treatment with dual nucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected infants with less advanced disease in a resource-limited setting: a multi-center study in Thailand 1998-2000.
Topics: Developing Countries; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine | 2005 |
Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/microl.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Candidiasis; CD4 Lymphocyte Count; Disease Progression; Drug Administration Schedule; Esophageal Diseases; Female; HIV; Humans; Male; Middle Aged; Treatment Outcome; Uganda; Zidovudine; Zimbabwe | 2008 |
Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients.
Topics: Adult; Antiviral Agents; Base Sequence; CD4 Lymphocyte Count; Codon; Cohort Studies; Disease Progression; Double-Blind Method; Drug Resistance, Microbial; Female; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Male; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Zidovudine | 1995 |
A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Disease Progression; Disease-Free Survival; Double-Blind Method; Follow-Up Studies; HIV Infections; Humans; Male; Proportional Hazards Models; Survival Analysis; Time Factors; Zidovudine | 1995 |
A controlled trial of zidovudine in primary human immunodeficiency virus infection.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Disease Progression; Disease-Free Survival; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Middle Aged; RNA, Viral; Time Factors; Zidovudine | 1995 |
A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Body Weight; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Female; Growth; HIV Core Protein p24; HIV Infections; Humans; Infant; Male; Stavudine; Survival Rate; Zidovudine | 1995 |
A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Complex; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Evaluation; Drug Tolerance; Female; Humans; Male; Middle Aged; Pancreatitis; Survival Rate; Treatment Outcome; Zidovudine | 1995 |
Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group.
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Resistance, Microbial; Female; HIV Infections; Humans; Male; Prospective Studies; Zidovudine | 1995 |
Five-year follow-up of a phase I study of didanosine in patients with advanced human immunodeficiency virus infection.
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Survival Rate; Zidovudine | 1995 |
Resistance, drug failure, and disease progression.
Topics: Antiviral Agents; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Nevirapine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1994 |
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.
Topics: Adult; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; HIV Core Protein p24; HIV Infections; Humans; Injections, Subcutaneous; Male; Middle Aged; Patient Compliance; Pentamidine; Pneumonia, Pneumocystis; Prognosis; Proportional Hazards Models; Thymopentin; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1995 |
Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; CD4 Lymphocyte Count; Disease Progression; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Regression Analysis; Risk Factors; Survival Rate; Treatment Outcome; Zidovudine | 1995 |
Aerosolized pentamidine as primary prophylaxis for Pneumocystis carinii pneumonia: efficacy, mortality and morbidity.
Topics: Absenteeism; Acquired Immunodeficiency Syndrome; Adult; Aerosols; AIDS-Related Opportunistic Infections; Disease Progression; Female; Follow-Up Studies; Hospitalization; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; Risk Factors; Sweden; Zidovudine | 1994 |
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Disease Progression; Double-Blind Method; Female; HIV Core Protein p24; Humans; Lymphocyte Count; Male; Zalcitabine; Zidovudine | 1995 |
Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antiviral Agents; Biomarkers; Biopterins; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Follow-Up Studies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Male; Neopterin; Receptors, Tumor Necrosis Factor; Solubility; Zidovudine | 1995 |
Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Longitudinal Studies; Male; Randomized Controlled Trials as Topic; Survival Rate; Veterans; Zidovudine | 1996 |
A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antiviral Agents; Disease Progression; Drug Therapy, Combination; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Sarcoma, Kaposi; Survival Rate; Zidovudine | 1996 |
Combination therapy with ZDV + DDI versus ZDV + DDC in patients with progression of HIV-infection under treatment with ZDV.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome; Zalcitabine; Zidovudine | 1996 |
Randomized study of the tolerance and efficacy of high- versus low-dose zidovudine in human immunodeficiency virus-infected children with mild to moderate symptoms (AIDS Clinical Trials Group 128). Pediatric AIDS Clinical Trials Group.
Topics: AIDS Dementia Complex; Antiviral Agents; Child; Child, Preschool; Disease Progression; Double-Blind Method; Drug Administration Schedule; Female; HIV Core Protein p24; HIV Infections; Humans; Infant; Liver; Male; Neuropsychological Tests; Zidovudine | 1996 |
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protoco
Topics: Adult; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Erythema; Female; HIV Infections; HIV-1; Humans; Male; Nevirapine; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 1996 |
Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; HIV Seropositivity; Humans; Longitudinal Studies; Male; Proportional Hazards Models; Zalcitabine; Zidovudine | 1996 |
Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Phenotype; RNA, Viral; Zalcitabine; Zidovudine | 1996 |
Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; AIDS-Related Opportunistic Infections; Antiviral Agents; Body Weight; CD4 Lymphocyte Count; Didanosine; Disease Progression; Female; HIV-1; Humans; Male; Pancreatitis; Zidovudine | 1996 |
Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee.
Topics: Adolescent; Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Male; Survival Analysis; Zalcitabine; Zidovudine | 1996 |
A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Didanosine; Disease Progression; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Zidovudine | 1996 |
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Proportional Hazards Models; Treatment Outcome; Zidovudine | 1996 |
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Phenotype; Proportional Hazards Models; RNA, Viral; Treatment Outcome; Virus Replication; Zidovudine | 1996 |
Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Rese
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Male; Risk; Survival Analysis; Zalcitabine; Zidovudine | 1996 |
HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Predictive Value of Tests; Proportional Hazards Models; RNA, Viral; Zidovudine | 1996 |
The Alpha trial: European/Australian randomized double-blind trial of two doses of didanosine in zidovudine-intolerant patients with symptomatic HIV disease. Alpha International Coordinating Committee.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Tolerance; Female; HIV Core Protein p24; HIV Infections; Humans; Male; Pancreatitis; Zidovudine | 1996 |
The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
Topics: Adjuvants, Immunologic; Adult; Antigen-Antibody Complex; Antiviral Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Predictive Value of Tests; Prognosis; Retrospective Studies; RNA, Viral; Thymopentin; Viral Load; Zidovudine | 1996 |
Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiviral Agents; Candida albicans; CD4 Lymphocyte Count; Cross-Over Studies; Disease Progression; Double-Blind Method; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; Humans; Hypersensitivity, Delayed; Male; Middle Aged; Mumps; Poly I-C; Poly U; RNA, Double-Stranded; Skin Tests; Tetanus; Trichophyton; Zidovudine | 1996 |
Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
Topics: Adult; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; HIV Infections; Humans; Male; Nausea; Neutropenia; Stavudine; Vomiting; Zidovudine | 1997 |
Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trials.
Topics: Adolescent; Adult; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Disease Progression; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; United States; Zidovudine | 1997 |
Italian multicentre study of didanosine compassionate use in advanced HIV infection. Italian BMS-906 Study Group.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; AIDS Dementia Complex; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Resistance, Microbial; Female; HIV Infections; Humans; Immunocompromised Host; Italy; Male; Middle Aged; Multivariate Analysis; Pancreatitis; Treatment Outcome; Zidovudine | 1997 |
Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial.
Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Health Services; HIV-1; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1997 |
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Disease Progression; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; Humans; Infant; Male; Treatment Outcome; Zidovudine | 1997 |
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Drug Therapy, Combination; HIV-1; Humans; Monitoring, Physiologic; Nevirapine; Phenotype; Prospective Studies; Pyridines; RNA, Viral; Viral Load; Zidovudine | 1997 |
Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; HIV-1; Humans; Monitoring, Physiologic; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 1997 |
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Didanosine; Disease Progression; Female; HIV Core Protein p24; HIV Infections; Humans; Male; Risk; Zidovudine | 1997 |
Impact of treatment changes on the interpretation of the Concorde trial.
Topics: Acquired Immunodeficiency Syndrome; Disease Progression; Drug Administration Schedule; Follow-Up Studies; HIV Infections; Humans; Treatment Outcome; Zidovudine | 1997 |
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Zidovudine | 1997 |
Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Patient Compliance; Patient Dropouts; Treatment Refusal; Zidovudine | 1997 |
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Middle Aged; Multivariate Analysis; Nucleosides; Prospective Studies; Protease Inhibitors; Risk Factors; Survival Analysis; Treatment Outcome; Zidovudine | 1997 |
Predicting outcomes in HIV-infected veterans: I. Progression to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Double-Blind Method; Female; HIV Infections; Humans; Male; Markov Chains; Predictive Value of Tests; Severity of Illness Index; Treatment Outcome; Veterans; Zidovudine | 1997 |
A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team.
Topics: Anti-HIV Agents; Bias; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Male; Neutropenia; Stavudine; Zidovudine | 1998 |
Induction of specific T-cell responses in HIV infection.
Topics: AIDS Vaccines; Anti-HIV Agents; Apoptosis; CD4 Lymphocyte Count; Combined Modality Therapy; Disease Progression; HIV Antigens; HIV Envelope Protein gp160; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Receptors, Antigen, T-Cell, alpha-beta; Receptors, CCR5; T-Lymphocytes; Vaccination; Vaccines, Synthetic; Viral Load; Zidovudine | 1998 |
Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network Investigators.
Topics: Adult; AIDS Vaccines; Anti-HIV Agents; CD4 Lymphocyte Count; Combined Modality Therapy; Disease Progression; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Hypersensitivity, Delayed; Lymphocyte Count; Male; Middle Aged; Treatment Outcome; Vaccination; Viral Load; Zidovudine | 1998 |
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team.
Topics: Adult; Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; Didanosine; Dideoxynucleosides; Disease Progression; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Multivariate Analysis; Prognosis; Reverse Transcriptase Inhibitors; RNA, Viral; Zalcitabine; Zidovudine | 1998 |
The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count.
Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; RNA, Viral; Treatment Outcome; Viral Load; Zalcitabine; Zidovudine | 1998 |
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; RNA, Viral; Viral Load; Zidovudine | 1998 |
Studies of antiretroviral therapy in the Multicenter AIDS Cohort Study.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotic Prophylaxis; Cohort Studies; Databases, Factual; Disease Progression; Drug Resistance, Microbial; Humans; Male; Outcome Assessment, Health Care; Prognosis; Zidovudine | 1998 |
Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.
Topics: Adult; Anti-HIV Agents; Antineoplastic Agents; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; Humans; Interferon-alpha; Male; Prospective Studies; Sarcoma, Kaposi; Zidovudine | 1998 |
A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.
Topics: Adolescent; Anti-HIV Agents; CD4 Antigens; Child; Child, Preschool; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Male; Neurodegenerative Diseases; Polymerase Chain Reaction; RNA, Viral; Survival Rate; Zidovudine | 1998 |
Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study.
Topics: Anti-HIV Agents; Disease Progression; Double-Blind Method; Female; France; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pregnancy Outcome; United States; Zidovudine | 1998 |
Long-term pattern of HIV-1 RNA load in perinatally infected children.
Topics: CD4 Lymphocyte Count; Child, Preschool; Disease Progression; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Linear Models; Male; Monitoring, Physiologic; Pregnancy; Prospective Studies; Risk Factors; RNA, Viral; Sensitivity and Specificity; Statistics, Nonparametric; Sweden; Viral Load; Viremia; Zidovudine | 1999 |
Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods.
Topics: Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Disease Progression; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Multivariate Analysis; Outcome Assessment, Health Care; Perinatal Care; Prenatal Care; RNA, Viral; Zidovudine | 2000 |
The CCR5Delta32 allele slows disease progression of human immunodeficiency virus-1-infected children receiving antiretroviral treatment.
Topics: Alleles; Anti-HIV Agents; Child, Preschool; Clinical Trials as Topic; Didanosine; Disease Progression; Disease-Free Survival; Ethnicity; Gene Frequency; HIV Infections; HIV-1; Humans; Racial Groups; Receptors, CCR5; Sequence Deletion; Zidovudine | 2000 |
Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatric AIDS clinical trials 152 study team.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; AIDS Dementia Complex; Anti-HIV Agents; Brain; CD4 Lymphocyte Count; Child; Child, Preschool; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV-1; Humans; Infant; Intelligence Tests; Male; Neurologic Examination; Neuropsychological Tests; Predictive Value of Tests; Radiography; Regression Analysis; RNA, Viral; Zidovudine | 2000 |
A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Confidence Intervals; Dideoxynucleosides; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Growth; HIV-1; Humans; Infant; Lamivudine; Male; RNA, Viral; Zidovudine | 2001 |
Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial.
Topics: Adolescent; Anti-HIV Agents; Area Under Curve; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Double-Blind Method; Female; Flow Cytometry; Follow-Up Studies; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Proportional Hazards Models; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Viral Load; Zidovudine | 2001 |
Indinavir gender study shows consistency.
Topics: Anti-HIV Agents; Disease Progression; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Male; Reverse Transcriptase Inhibitors; Sex Factors; Zidovudine | 1998 |
Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
Topics: Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Prognosis; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zalcitabine; Zidovudine | 2001 |
Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Disease Progression; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Count; Morbidity; Prognosis; Ritonavir; RNA, Viral; Saquinavir; Viral Load; Zidovudine | 2001 |
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Protocols; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Logistic Models; Male; Middle Aged; RNA, Viral; Viral Load; Zidovudine | 2001 |
104 other study(ies) available for zidovudine and Disease Exacerbation
| Article | Year |
|---|---|
Metabolic profiling of HIV infected individuals on an AZT-based antiretroviral treatment regimen reveals persistent oxidative stress.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Arginine; Biomarkers; Disease Progression; Glucose; Glutamates; Glutamine; Glutathione; HIV Infections; Humans; Oxidative Stress; Reproducibility of Results; Zidovudine | 2022 |
The Variation of Transcriptomic Perturbations is Associated with the Development and Progression of Various Diseases.
Topics: Acquired Immunodeficiency Syndrome; COVID-19; Disease Progression; Humans; Pulmonary Disease, Chronic Obstructive; Stroke Volume; Transcriptome; Ventricular Function, Left; Zidovudine | 2022 |
MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Resistance, Viral; Female; Gene Expression Regulation; HIV; Humans; Lamivudine; Leukocytes, Mononuclear; Male; MicroRNAs; Nevirapine; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2014 |
Mode of delivery and postpartum HIV-1 disease progression and mortality in a Kenyan cohort.
Topics: Adult; Anti-HIV Agents; Cause of Death; CD4 Lymphocyte Count; Cesarean Section; Disease Progression; Emergencies; Female; HIV Infections; HIV-1; Humans; Kenya; Maternal Mortality; Parturition; Postpartum Period; Prospective Studies; RNA, Viral; Young Adult; Zidovudine | 2014 |
Anaemia in pregnancy is associated with advanced HIV disease.
Topics: Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; Humans; Incidence; Multivariate Analysis; Pregnancy; Pregnancy Complications, Hematologic; Prevalence; Retrospective Studies; Risk Factors; South Africa; Urinary Tract Infections; Zidovudine | 2014 |
[HIV encephalopathy due to drug resistance despite 2-year suppression of HIV viremia by cART].
Topics: AIDS Dementia Complex; Anti-Retroviral Agents; Central Nervous System; Cognition Disorders; Darunavir; Disease Progression; Drug Resistance, Viral; Drug Substitution; HIV; HIV Infections; Humans; Male; Middle Aged; Pyrrolidinones; Raltegravir Potassium; Ritonavir; RNA, Viral; Sulfonamides; Time Factors; Viremia; Zidovudine | 2014 |
[Comparative and evolutionary profile of people infected with HIV on antiretroviral therapy in Kinshasa, Democratic Republic of Congo].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Democratic Republic of the Congo; Disease Progression; Drug Combinations; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Ritonavir; Zidovudine | 2014 |
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions.
Topics: Adult; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biopsy; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Doxorubicin; Drug Eruptions; Epidermis; Etoposide; Exanthema; Folic Acid Antagonists; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Recombinant Proteins; Vincristine; Zidovudine | 2009 |
The obstetric face and challenge of HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Developing Countries; Disease Progression; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Maternal Mortality; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination; World Health Organization; Zidovudine | 2009 |
Treatment interruption after pregnancy: effects on disease progression and laboratory findings.
Topics: Adult; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Disease Progression; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Logistic Models; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; RNA, Viral; Viral Load; Zidovudine | 2009 |
Preventing perinatal transmission of HIV: your vigilance can pay off.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Disease Progression; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prenatal Care; Risk Assessment; Zidovudine | 2010 |
C868T single nucleotide polymorphism and HIV type 1 disease progression among postpartum women in Kenya.
Topics: Adult; Arginine; CD4 Antigens; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; Genotype; HIV Infections; HIV-1; Humans; Infant, Newborn; Kenya; Polymorphism, Single Nucleotide; Postpartum Period; Pregnancy; Tryptophan; Viral Load; Zidovudine | 2012 |
[Adult T-cell leukemia/lymphoma. Therapeutic aspects].
Topics: Anti-HIV Agents; Antineoplastic Agents; Disease Progression; Drug Therapy, Combination; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Pain; Recurrence; Zidovudine | 2001 |
HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cell Line; Didanosine; Disease Progression; Evolution, Molecular; Genetic Variation; HIV Infections; HIV-1; Humans; Male; Phenotype; Receptors, CCR5; Receptors, CXCR4; Receptors, HIV; Recombinant Fusion Proteins; Virus Replication; Zidovudine | 2003 |
Parametric randomization-based methods for correcting for treatment changes in the assessment of the causal effect of treatment.
Topics: Anti-HIV Agents; Disease Progression; Drug Administration Schedule; HIV Infections; Humans; Models, Statistical; Randomized Controlled Trials as Topic; Research Design; Time Factors; Zidovudine | 2004 |
Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Databases, Factual; Disease Progression; Disease-Free Survival; Follow-Up Studies; HIV Infections; HIV Wasting Syndrome; Humans; Proportional Hazards Models; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2004 |
Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Anti-HIV Agents; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; HIV Infections; Humans; Male; Regression Analysis; Risk Factors; Time Factors; Viral Load; Zidovudine | 2004 |
Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Topics: Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; Didanosine; Disease Progression; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Interferons; Interleukin-6; Male; Neopterin; Predictive Value of Tests; Risk Factors; Zidovudine | 2005 |
Clinical and immunologic characteristics and therapeutic interventions in children born to human immunodeficiency virus-infected mothers in southern Taiwan.
Topics: Anti-HIV Agents; Bottle Feeding; Cesarean Section; Child; Child, Preschool; Disease Progression; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Male; Pregnancy; Pregnancy Complications, Infectious; Taiwan; Zidovudine | 2005 |
HIV leucoencephalopathy and TNFalpha expression in neurones.
Topics: Adult; AIDS Dementia Complex; Anti-Retroviral Agents; Basal Ganglia; Biopsy; Brain; Diffusion Magnetic Resonance Imaging; Disease Progression; Follow-Up Studies; Frontal Lobe; HIV Envelope Protein gp41; Humans; Macrophages; Male; Microglia; Middle Aged; Neurologic Examination; Neurons; Neuropsychological Tests; Saquinavir; Stavudine; Treatment Outcome; Tumor Necrosis Factor-alpha; Zidovudine | 2005 |
[HIV infection presenting with bilateral optic neuropathy].
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Disease Progression; Drug Therapy, Combination; Evoked Potentials, Visual; Facial Nerve Diseases; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Ischemia; Lamivudine; Lopinavir; Male; Meningitis, Viral; Methylprednisolone; Middle Aged; Optic Disk; Optic Nerve Diseases; Polyradiculopathy; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Visual Fields; Zidovudine | 2006 |
Disease progression among HIV-infected children who receive perinatal zidovudine prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Zidovudine | 2007 |
Transcriptional profiling for understanding the basis of mitochondrial involvement in disease and toxicity using the mitochondria-specific MitoChip.
Topics: Animals; Disease Progression; DNA, Mitochondrial; Female; Gene Expression Profiling; Lamivudine; Mice; Mitochondria; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Inhibitors; Zidovudine | 2007 |
Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Hemoglobins; HIV Infections; HIV-1; Humans; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine | 2007 |
Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Cohort Studies; Disease Progression; Follow-Up Studies; France; HIV Infections; HIV-1; Humans; Infant; Kaplan-Meier Estimate; Time Factors; Zidovudine | 2007 |
[Early intervention in HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Disease Progression; HIV Infections; Humans; Zidovudine | 1992 |
Rapid CD4+ cell decline after sexual transmission of a zidovudine-resistant syncytium-inducing isolate of HIV-1.
Topics: Adult; CD4 Lymphocyte Count; Codon; Cytopathogenic Effect, Viral; Disease Progression; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; RNA-Directed DNA Polymerase; Time Factors; Zidovudine | 1994 |
Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Worki
Topics: Adult; Clinical Trials as Topic; Codon; Disease Progression; DNA, Viral; Drug Resistance, Microbial; Female; Genetic Markers; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Risk Factors; RNA-Directed DNA Polymerase; Zidovudine | 1995 |
Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Analysis of Variance; Bisexuality; CD4-CD8 Ratio; Disease Progression; Follow-Up Studies; HIV Antibodies; HIV Core Protein p24; HIV Envelope Protein gp41; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Male; Multivariate Analysis; Predictive Value of Tests; Prognosis; Time Factors; Zidovudine | 1995 |
Zidovudine is beneficial in human immunodeficiency virus associated nephropathy.
Topics: Adult; AIDS-Associated Nephropathy; Case-Control Studies; CD4 Lymphocyte Count; Disease Progression; Female; Humans; Kidney Failure, Chronic; Male; Prospective Studies; Zidovudine | 1995 |
Correlation of clinical progression in human immunodeficiency virus-infected children with in vitro zidovudine resistance measured by a direct quantitative peripheral blood lymphocyte assay.
Topics: Child; Child, Preschool; Disease Progression; Drug Resistance, Microbial; Follow-Up Studies; HIV; HIV Core Protein p24; HIV Infections; Humans; Infant; Lymphocytes; Microbial Sensitivity Tests; Zidovudine | 1995 |
Zidovudine regimen in pediatric AIDS trial halted, other regimens shown superior.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Didanosine; Disease Progression; Drug Therapy, Combination; Humans; Infant; Zidovudine | 1995 |
Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay.
Topics: Acyclovir; CD4 Lymphocyte Count; Didanosine; Disease Progression; DNA, Single-Stranded; Drug Therapy, Combination; Gene Amplification; Genes, pol; HIV Seropositivity; HIV-1; Humans; Longitudinal Studies; Nucleic Acid Hybridization; Oligonucleotide Probes; Reproducibility of Results; RNA, Viral; Sensitivity and Specificity; Zidovudine | 1995 |
Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies.
Topics: Acquired Immunodeficiency Syndrome; Age Factors; Analysis of Variance; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Genes, MHC Class I; Genes, MHC Class II; Haplotypes; Hemophilia A; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; HIV Seropositivity; HIV-1; Humans; Incidence; Nuclear Family; Proportional Hazards Models; Retrospective Studies; Zidovudine | 1995 |
Modelling progression of CD4-lymphocyte count and its relationship to survival time.
Topics: Acquired Immunodeficiency Syndrome; Biometry; CD4 Lymphocyte Count; Disease Progression; Humans; Mathematics; Models, Statistical; Probability; Randomized Controlled Trials as Topic; Survival Rate; Time Factors; Zidovudine | 1994 |
CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Disease Progression; Factor VIII; Fluconazole; Hemophilia A; HIV Infections; Humans; Male; Middle Aged; Pentamidine; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1994 |
[Zidovudine for asymptomatic HIV patients?].
Topics: Disease Progression; HIV Infections; Humans; Zidovudine | 1994 |
Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
Topics: Adult; Age Factors; Antiviral Agents; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Cohort Studies; Comorbidity; Databases, Factual; Disease Progression; District of Columbia; Female; HIV Antibodies; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Immunoglobulin A; Italy; Life Tables; London; Male; Middle Aged; New York City; Ontario; Prognosis; Regression Analysis; Risk; Risk Factors; Scotland; Sex Factors; Sexual Behavior; Substance Abuse, Intravenous; Survival Analysis; Time Factors; Zidovudine | 1994 |
Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Topics: Adolescent; Adult; Anemia; Blood Coagulation Disorders; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Hemophilia A; HIV Infections; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Pancytopenia; Thrombocytopenia; Treatment Outcome; Zidovudine | 1994 |
MT-2 cell tropism of human immunodeficiency virus type 1 isolates as a marker for response to treatment and development of drug resistance.
Topics: Adult; Biomarkers; CD4 Lymphocyte Count; Cell Line; Didanosine; Disease Progression; Drug Resistance, Microbial; Female; HIV Infections; HIV-1; Humans; Male; Prognosis; Virus Replication; Zidovudine | 1994 |
Spontaneous in vitro anti-human immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults.
Topics: Adult; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Disease Progression; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; Humans; Immunoglobulin G; Leukocytes, Mononuclear; Male; Middle Aged; Prospective Studies; Zidovudine | 1994 |
The European Collaborative Study: clinical and immunological characteristics of HIV 1-infected pregnant women.
Topics: Antiviral Agents; Breast Feeding; CD4 Lymphocyte Count; Disease Progression; Europe; Female; HIV Infections; Humans; Multivariate Analysis; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Prospective Studies; Zidovudine | 1995 |
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Disease Progression; HIV Infections; HIV-1; Humans; Life Tables; Outcome Assessment, Health Care; Regression Analysis; Retrospective Studies; Risk; RNA, Viral; Zidovudine | 1996 |
Zidovudine in patients with HIV infection.
Topics: Disease Progression; Drug Administration Schedule; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
Zidovudine in patients with HIV infection.
Topics: Disease Progression; Drug Administration Schedule; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
No evidence of a higher risk of progression to AIDS in patients with HIV-1-related severe thrombocytopenia.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; HIV Infections; HIV-1; Humans; Male; Platelet Count; Prognosis; Risk Factors; Thrombocytopenia; Zidovudine | 1996 |
Analysis of an HIV-infected cohort followed for as long as 15 years after seroconversion.
Topics: Adult; Age Factors; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; Hemophilia A; Hemophilia B; HIV Infections; Humans; Lymphocyte Count; Male; von Willebrand Diseases; Zidovudine | 1996 |
Antiretroviral drug treatment for HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Disease Progression; HIV Infections; Humans; Protease Inhibitors; Reverse Transcriptase Inhibitors; Zidovudine | 1996 |
Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985.
Topics: Adult; Age Factors; Antiviral Agents; CD4 Lymphocyte Count; Disease Progression; Follow-Up Studies; Histocompatibility Testing; HIV Infections; HIV Seropositivity; Humans; Male; Statistics as Topic; Substance Abuse, Intravenous; United Kingdom; Zidovudine | 1996 |
The Edinburgh cohort of HIV-positive injecting drug users at 10 years after infection: a case-control study of the evolution of dementia.
Topics: Adult; AIDS Dementia Complex; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Cognition; Disease Progression; Evoked Potentials, Auditory; Female; HIV Seropositivity; Humans; Male; Neuropsychological Tests; Psychomotor Performance; Substance Abuse, Intravenous; United Kingdom; Zidovudine | 1996 |
Lactic dehydrogenase-immunoglobulin G kappa complex in a patient with idiopathic interstitial pneumonia.
Topics: Antigen-Antibody Complex; Bronchoalveolar Lavage Fluid; Disease Progression; Dyspnea; Female; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Immunosuppressive Agents; Isoenzymes; L-Lactate Dehydrogenase; Lung Diseases, Interstitial; Middle Aged; Prednisolone; Zidovudine | 1996 |
Prognostic value of oral candidosis and hairy leukoplakia in 111 Mexican HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-HIV Agents; Candidiasis, Oral; Cohort Studies; Disease Progression; Female; Follow-Up Studies; HIV Infections; Humans; Leukoplakia, Hairy; Linear Models; Lymphocyte Count; Male; Mexico; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Zidovudine | 1996 |
Prevalence of zidovudine-resistant HIV-1 among rapid progressors.
Topics: Adult; Anti-HIV Agents; Codon; Cohort Studies; Disease Progression; Drug Resistance, Multiple; Female; HIV-1; Humans; Male; Mutation; Zidovudine | 1996 |
Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy.
Topics: AIDS Dementia Complex; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Disease Progression; Drug Resistance, Microbial; Follow-Up Studies; Genes, pol; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Infant; Point Mutation; Polymerase Chain Reaction; RNA, Viral; Zidovudine | 1996 |
Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine.
Topics: Adult; Anti-HIV Agents; Antibodies, Bacterial; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Didanosine; Disease Progression; DNA, Viral; HIV Infections; HIV-1; Humans; Immunoglobulin G; Influenza Vaccines; Lymphocyte Activation; Middle Aged; Pneumococcal Infections; Polysaccharides, Bacterial; Proviruses; Receptors, Interleukin-2; RNA, Viral; Time Factors; Vaccination; Vaccines; Viral Load; Zidovudine | 1996 |
Treatment of late-state HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Combinations; HIV Infections; Humans; Randomized Controlled Trials as Topic; Reproducibility of Results; Reverse Transcriptase Inhibitors; Treatment Outcome; Zalcitabine; Zidovudine | 1997 |
Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Cohort Studies; Disease Progression; Female; HIV Seropositivity; Humans; Male; Middle Aged; Risk Factors; Treatment Outcome; Zidovudine | 1997 |
Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression.
Topics: Cross-Sectional Studies; Disease Progression; DNA, Circular; DNA, Viral; HIV Infections; HIV Long Terminal Repeat; HIV-1; Humans; Leukocytes, Mononuclear; Longitudinal Studies; Molecular Sequence Data; Polymerase Chain Reaction; Risk Factors; Virus Integration; Zidovudine | 1997 |
Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline.
Topics: Anti-HIV Agents; beta 2-Microglobulin; CD4 Lymphocyte Count; Didanosine; Disease Progression; DNA, Viral; Drug Therapy, Combination; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Longitudinal Studies; RNA, Viral; Stavudine; Viral Load; Viremia; Virus Replication; Zalcitabine; Zidovudine | 1997 |
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Drug Resistance, Microbial; Female; Genetic Variation; HIV Infections; HIV-1; Humans; Male; Phenotype; RNA, Viral; Saquinavir; Time Factors; Zidovudine | 1997 |
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS.
Topics: Animals; Antiviral Agents; Disease Progression; DNA, Viral; Drug Therapy, Combination; Female; Glutathione; Hematologic Tests; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Proviruses; Zidovudine | 1997 |
Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1.
Topics: Adult; Analysis of Variance; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Drug Resistance; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Male; Mutation; Polymerase Chain Reaction; RNA, Viral; Zidovudine | 1997 |
[Initial administration of a protease inhibitor delays the progression of AIDS by half time].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Disease Progression; HIV Infections; HIV Protease Inhibitors; Humans; Time Factors; Zalcitabine; Zidovudine | 1997 |
[Frequency and characteristics of patients treated with zidovudine and absence of progression of HIV infection].
Topics: Adult; Anti-HIV Agents; Disease Progression; Female; HIV Infections; Humans; Male; Zidovudine | 1997 |
[Historical cohort study on bacterial pneumonias as predictors of the progression of the human immunodeficiency virus disease].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Cohort Studies; Disease Progression; Female; Humans; Male; Pneumonia, Bacterial; Zidovudine | 1997 |
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Dideoxynucleosides; Disease Progression; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Stavudine; Survival Analysis; Zalcitabine; Zidovudine | 1998 |
Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; DNA, Circular; DNA, Viral; Follow-Up Studies; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Phenotype; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; RNA, Viral; Viremia; Zidovudine | 1998 |
Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral Research.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Female; Follow-Up Studies; HIV Infections; Humans; Male; Military Personnel; Proportional Hazards Models; Time Factors; United States; Zidovudine | 1998 |
Determinants of progression to AIDS in HIV-infected individuals: an update from the Italian Seroconversion Study.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Cohort Studies; Disease Progression; Female; HIV; Humans; Italy; Male; Middle Aged; Zidovudine | 1998 |
Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapy.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Didanosine; Dideoxynucleosides; Disease Progression; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Genetic Variation; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Point Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Zalcitabine; Zidovudine | 1998 |
Pneumocystis carinii pneumonia prophylaxis and early clinical manifestations of severe perinatal human immunodeficiency virus type 1 infection. Northern California Pediatric HIV Consortium.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Anti-Infective Agents; Child; Child, Preschool; Cohort Studies; Disease Progression; Female; HIV-1; Humans; Incidence; Infant; Infant, Newborn; Pneumonia, Pneumocystis; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1998 |
Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus.
Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Cohort Studies; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infant; Lamivudine; Male; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Viral Load; Zidovudine | 1998 |
Tumor necrosis factor beta and soluble APO-1/Fas independently predict progression to AIDS in HIV-seropositive patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; beta 2-Microglobulin; Biomarkers; Case-Control Studies; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; fas Receptor; Female; HIV Seropositivity; Humans; Lymphotoxin-alpha; Male; Predictive Value of Tests; Regression Analysis; Reverse Transcriptase Inhibitors; Solubility; Zidovudine | 1998 |
Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.
Topics: Anti-HIV Agents; beta 2-Microglobulin; Biomarkers; CD4 Lymphocyte Count; Disease Progression; Drug Administration Schedule; Follow-Up Studies; HIV Core Protein p24; HIV Infections; Humans; Proportional Hazards Models; Time Factors; Treatment Outcome; Zidovudine | 1998 |
Analysis of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine.
Topics: Anti-HIV Agents; Child; Child, Preschool; Codon; Cohort Studies; Disease Progression; Female; Genetic Variation; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Infant; Male; Mutation; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Zidovudine | 1998 |
A model of primary HIV-1 infection.
Topics: Adult; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Disease Progression; Flow Cytometry; HIV Antibodies; HIV Infections; HIV-1; Humans; Immunologic Memory; Middle Aged; Models, Immunological; RNA, Viral; Viral Load; Zidovudine | 1998 |
An asymptomatic 41-year-old man with HIV infection.
Topics: Adaptation, Psychological; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Decision Making; Disease Progression; HIV Infections; Humans; Male; Viral Load; Zidovudine | 1999 |
AIDS in the 1990s: managing a decade-long disease.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Continuity of Patient Care; Disease Progression; HIV-1; Humans; Lymphocyte Depletion; Virus Replication; Zidovudine | 1995 |
Role of macrophage protection in the development of murine AIDS.
Topics: Animals; Anti-HIV Agents; Brain; CD4-CD8 Ratio; Dideoxynucleotides; Disease Progression; DNA, Viral; Drug Carriers; Drug Therapy, Combination; Erythrocytes; Female; Glutathione; Kidney; Liver; Lymphocytes; Lymphoid Tissue; Macrophages; Mice; Mice, Inbred C57BL; Mitogens; Murine Acquired Immunodeficiency Syndrome; Thymine Nucleotides; Zidovudine | 1999 |
Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. The Italian register for HIV Infection in Children.
Topics: Anti-HIV Agents; Child; Child, Preschool; Disease Progression; Female; HIV Infections; HIV-1; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Retrospective Studies; Zidovudine | 1999 |
Strategies for cohort sampling under the Cox proportional hazards model, application to an AIDS clinical trial.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Computer Simulation; Disease Progression; HIV Infections; Humans; Likelihood Functions; Models, Biological; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Sampling Studies; Zidovudine | 1999 |
Randomization-based methods for correcting for treatment changes: examples from the Concorde trial.
Topics: Anti-HIV Agents; Data Interpretation, Statistical; Disease Progression; Drug Administration Schedule; HIV Infections; Humans; Models, Statistical; Randomized Controlled Trials as Topic; Research Design; Zidovudine | 1999 |
Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Didanosine; Disease Progression; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Incidence; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; RNA, Viral; Salvage Therapy; Saquinavir; Stavudine; Switzerland; Treatment Failure; Viral Load; Zalcitabine; Zidovudine | 1999 |
AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in São Paulo, Brazil.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Distribution; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Brazil; CD4 Lymphocyte Count; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; HIV Seropositivity; Hospitals, University; Humans; Incidence; Male; Middle Aged; Pneumonia, Pneumocystis; Risk-Taking; Sex Distribution; Survival Rate; Tuberculosis; Zidovudine | 1999 |
The impact of zidovudine on dementia-free survival in a population of HIV-positive men and women on antiretroviral therapy.
Topics: Adult; AIDS Dementia Complex; Anti-HIV Agents; British Columbia; CD4 Lymphocyte Count; Disease Progression; Disease-Free Survival; Female; HIV Infections; Humans; Male; Zidovudine | 2000 |
Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Blood Component Transfusion; CD4 Lymphocyte Count; Cohort Studies; Cytomegalovirus Infections; Disease Progression; Follow-Up Studies; Hemophilia A; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; RNA, Viral; Time Factors; Zidovudine | 2000 |
Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Female; Gestational Age; HIV Infections; HIV Seropositivity; HIV-1; Humans; Infant; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk Factors; Zidovudine | 2000 |
Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Topics: Adolescent; Adult; Aged; Anemia; Anti-HIV Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Disease Progression; Female; Hemoglobins; HIV Infections; HIV Seropositivity; HIV-1; Humans; Middle Aged; Multivariate Analysis; Odds Ratio; Prevalence; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine | 2001 |
ACTG 320 trial halted as three-drug arm proves superior.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; United States; Zidovudine | 1997 |
3TC: combination trial stopped early as clinical benefit shown.
Topics: Antiviral Agents; Clinical Trials as Topic; Didanosine; Disease Progression; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Placebos; Treatment Failure; Zalcitabine; Zidovudine | 1996 |
FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Delavirdine; Didanosine; Disease Progression; Drug Approval; Drug Industry; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indoles; Piperazines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Viral Load; Zidovudine | 1996 |
Study shows three drugs better than two.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Stavudine; United States; Zidovudine | 1997 |
Study confirms that protease inhibitor cocktail can delay HIV disease progression and death.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; United States; Zidovudine | 1997 |
NIAID researchers present new findings at retrovirus meeting. National Institute of Allergy and Infectious Diseases.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chemokines; Clinical Trials as Topic; Clone Cells; Dendritic Cells; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-10; Killer Cells, Natural; Lamivudine; Male; Nevirapine; Pyridines; Receptors, Cytokine; Reverse Transcriptase Inhibitors; Ritonavir; Virus Replication; Zalcitabine; Zidovudine | 1997 |
Spring cleaning in trial land.
Topics: Anti-HIV Agents; Brazil; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Saquinavir; Stavudine; United States; Viral Load; Zidovudine | 1997 |
Combo therapy for children and adolescents.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Clinical Trials as Topic; Didanosine; Disease Progression; Drug Therapy, Combination; HIV Infections; Humans; Infant; Lamivudine; Zidovudine | 1997 |
Two drugs better than one for children.
Topics: Anti-HIV Agents; Child; Disease Progression; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Zidovudine | 1997 |
HIV & pregnancy: the basics.
Topics: AIDS Serodiagnosis; Anti-HIV Agents; Breast Feeding; Clinical Trials as Topic; Disease Progression; Female; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Viral Load; Zidovudine | 1998 |
ACTG 076 and reduction of perinatal transmission.
Topics: Adolescent; Adult; Animals; Anti-HIV Agents; Black or African American; CD4 Lymphocyte Count; Disease Progression; Hispanic or Latino; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Mandatory Testing; Mice; National Institutes of Health (U.S.); Pregnancy; Pregnancy Complications, Infectious; United States; United States Public Health Service; Zidovudine | 1997 |
Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Progression; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Longitudinal Studies; Lymphoid Tissue; Phenotype; Proviruses; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine | 2001 |
Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life.
Topics: Age Distribution; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Disease Progression; Europe; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Life Tables; Male; Severity of Illness Index; Survival Analysis; Zidovudine | 2001 |
Rapidly progressing peripheral neuropathy with lactic acidosis and coproporphyria in a patient with HTLV-I associated T-cell leukaemia treated with zidovudine.
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Disease Progression; Female; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Mitochondria; Peripheral Nervous System Diseases; Porphyrias; Zidovudine | 2001 |
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.
Topics: Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Disease Progression; Female; Hepatitis B Surface Antigens; Hepatitis C; HIV Seropositivity; HIV-1; Humans; Male; Proportional Hazards Models; Stavudine; Zidovudine | 2001 |
Summaries for patients. Predictors of outcomes in patients with HIV infection treated with indinavir, zidovudine, and lamivudine.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Protocols; Disease Progression; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; RNA, Viral; Viral Load; Zidovudine | 2001 |